Opportunity Information: Apply for RFA FD 13 010

  • The Food Drug Administration in the agriculture business and commerce consumer protection education employment, labor and training environment food and nutrition health information and statistics natural resources sector is offering a public funding opportunity titled "Pediatric Device Consortia Grant Program (P50)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.103 Food and Drug AdministrationResearch.
  • This funding opportunity was created on Mar 19, 2013 and posted on Mar 19, 2013.
  • Applicants must submit their applications by Jun 2, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $3,000,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $750,000.00 in funding.
  • The number of recipients for this funding is limited to 5 candidate(s).
  • Eligible applicants include: City or township governments County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Private institutions of higher education Special district governments State governments.
  • The following types of Higher Education Institutions are encouraged to apply for FDA support as Public or Private Institutions of Higher Education Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISIs) Eligible Agencies of the Federal Government, other than Health and Human Services
Apply for RFA FD 13 010

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Pediatric Device Consortia Grant Program (P50), funded by the U.S. Food and Drug Administration (FDA) through the Office of Orphan Products Development (OOPD), is designed to speed up and strengthen the pipeline of medical devices made specifically for children. Rather than paying for a single product to be built, the program funds nonprofit consortia that can support many pediatric device projects at once by providing hands-on expertise, infrastructure, and coordinated services to innovators. The overall aim is to make it easier for promising pediatric device ideas to move from concept to development, testing, regulatory clearance pathways, and ultimately production and distribution.

A key point of this opportunity is that the applicants are expected to be nonprofit consortia, but they are not required to operate in isolation from industry. While the consortia themselves must be nonprofit entities, they can include partnerships and participation from for-profit companies, clinicians, engineers, manufacturers, investors, and other stakeholders who can help move pediatric device innovation forward. The FDA is essentially investing in a support ecosystem: a consortium that can repeatedly guide inventors and small companies through the technical, clinical, business, and regulatory hurdles that often slow pediatric devices more than adult devices.

The services the consortium provides are central to the grant. The FDA expects consortia to deliver expert advising and practical support to children’s device innovators, including business consulting (such as commercialization planning, reimbursement strategy considerations, market analysis, and funding readiness), and regulatory consulting (such as pathway planning, pre-submission strategy, quality system considerations, and general navigation of FDA device requirements). The program also emphasizes device testing capabilities, meaning the consortium should be able to help innovators access or conduct relevant testing services (for example, engineering verification, bench testing, safety assessments, prototyping support, or connections to labs and facilities). In other words, the consortium is expected to be a capable hub that reduces friction for multiple device teams, not simply a networking group.

Although the grant is administered under the FDA office that historically deals with orphan products, the scope here is broader than rare diseases. The opportunity explicitly states that it is intended to encompass devices for all pediatric conditions and diseases, not only rare conditions. The pediatric population is defined broadly as patients 21 years of age or younger at the time of diagnosis or treatment, and it includes neonates, infants, children, and adolescents. That definition matters because pediatric device needs vary significantly across these age groups, and consortia are expected to understand and address those differences when advising innovators.

From a funding and administrative standpoint, this is a discretionary grant opportunity (Funding Opportunity Number RFA-FD-13-010) with an estimated total program funding level of $3,000,000 and an expectation of about five awards. Individual awards have an anticipated ceiling of $750,000 and a floor of $250,000, and there is no cost-sharing or matching requirement. The listing is associated with CFDA number 93.103 (Food and Drug Administration Research). Key dates in the posted announcement included a posted/creation date of March 19, 2013, and an application closing date of June 2, 2013, with an archive date of July 2, 2013.

Eligibility is broad in the sense that multiple types of organizations can apply, including state and local governments, tribal governments and tribal organizations, special district governments, public and private institutions of higher education, and nonprofit organizations (including 501(c)(3) and certain non-501(c)(3) nonprofits, with details referenced in the full announcement). The notice also encourages applications from a range of higher-education institutions, including Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). This reflects an intent to build strong, diverse regional or national consortia that can connect clinical needs, engineering expertise, and commercialization resources.

In practical terms, a strong applicant for this program is typically an established consortium or an organization capable of operating like one: coordinating subject-matter experts, maintaining a structured intake and review process for device projects, offering repeatable advisory services, and demonstrating the ability to support several pediatric device efforts concurrently. Because the program is not meant to fund one device, the proposal needs to show how the consortium will identify, prioritize, and assist a portfolio of device innovators over the project period, and how it will measure success in moving multiple pediatric devices closer to real-world use.

For reference and support, the opportunity points applicants to the NIH Guide for Grants and Contracts for additional information and provides a grants management contact at FDA: Vieda Hubbard, Grants Management Specialist (301-827-7177, vieda.hubbard@fda.hhs.gov), for access or application-related issues.

Frequently Asked Questions (FAQs)

What is the Pediatric Device Consortia Grant Program (P50)?

The Pediatric Device Consortia Grant Program (P50) is a discretionary grant funded by the U.S. Food and Drug Administration (FDA) through the Office of Orphan Products Development (OOPD). It is designed to speed up and strengthen the pipeline of medical devices made specifically for children by funding nonprofit consortia that can support multiple pediatric device projects at once.

What is the main goal of this grant opportunity?

The main goal is to make it easier for promising pediatric device ideas to move from concept to development, testing, regulatory pathway planning, and ultimately production and distribution by investing in a consortium-based support ecosystem.

Does this grant fund the development of a single pediatric device?

No. The program is not intended to pay for a single product to be built. Instead, it funds nonprofit consortia that can provide coordinated services and infrastructure to assist many pediatric device projects concurrently.

Who is expected to apply for this grant?

Applicants are expected to be nonprofit consortia (or organizations capable of operating like a consortium) that can repeatedly guide innovators through technical, clinical, business, and regulatory hurdles that commonly slow pediatric device development.

Do consortia have to work independently of industry?

No. While the consortium entity itself must be nonprofit, it can include partnerships and participation from for-profit companies, clinicians, engineers, manufacturers, investors, and other stakeholders who can help move pediatric device innovation forward.

What types of services is the consortium expected to provide?

The FDA expects funded consortia to deliver hands-on expertise and practical support to pediatric device innovators. This includes business consulting, regulatory consulting, and support for device testing capabilities and access to relevant testing resources.

What business consulting support is referenced in the opportunity?

Examples of business consulting mentioned include commercialization planning, reimbursement strategy considerations, market analysis, and funding readiness support for pediatric device innovators.

What regulatory consulting support is referenced in the opportunity?

Examples of regulatory consulting mentioned include FDA pathway planning, pre-submission strategy, quality system considerations, and general navigation of FDA medical device requirements.

What does the opportunity mean by emphasizing device testing capabilities?

It means the consortium should be able to help innovators access or conduct relevant testing services, such as engineering verification, bench testing, safety assessments, prototyping support, or connecting teams to labs and facilities that can perform needed work.

Is this program limited to devices for rare diseases because it is administered through OOPD?

No. Although the grant is administered under the FDA office that historically deals with orphan products, the opportunity explicitly states it is intended to encompass devices for all pediatric conditions and diseases, not only rare conditions.

How does the opportunity define the pediatric population?

The pediatric population is defined broadly as patients 21 years of age or younger at the time of diagnosis or treatment, including neonates, infants, children, and adolescents.

Why does the age-group definition matter for applicants?

The opportunity notes that pediatric device needs vary significantly across neonates, infants, children, and adolescents, and consortia are expected to understand and address those differences when advising innovators.

What is the Funding Opportunity Number (FON) for this announcement?

The Funding Opportunity Number is RFA-FD-13-010.

What is the CFDA number associated with this opportunity?

The opportunity is associated with CFDA 93.103 (Food and Drug Administration Research).

How much total funding is estimated for the program?

The estimated total program funding level is $3,000,000.

How many awards does the FDA expect to make?

The announcement indicates an expectation of about five awards.

What is the anticipated funding range for individual awards?

Individual awards have an anticipated ceiling of $750,000 and a floor of $250,000.

Is cost-sharing or matching required?

No. The opportunity states there is no cost-sharing or matching requirement.

What types of organizations are eligible to apply?

Eligibility includes state and local governments, tribal governments and tribal organizations, special district governments, public and private institutions of higher education, and nonprofit organizations (including 501(c)(3) and certain non-501(c)(3) nonprofits, as referenced in the full announcement).

Does the opportunity encourage applications from specific types of higher-education institutions?

Yes. It encourages applications from a range of higher-education institutions, including Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).

What kind of consortium structure is described as a strong applicant?

A strong applicant is typically an established consortium (or an organization that can operate like one) with the ability to coordinate subject-matter experts, maintain a structured intake and review process for device projects, offer repeatable advisory services, and support several pediatric device efforts at the same time.

How should an applicant address the fact that the program supports multiple device projects?

The proposal should show how the consortium will identify, prioritize, and assist a portfolio of pediatric device innovators over the project period, and how it will measure success in moving multiple pediatric devices closer to real-world use.

What are the key dates listed in the announcement?

Key dates included a posted/creation date of March 19, 2013; an application closing date of June 2, 2013; and an archive date of July 2, 2013.

Where does the opportunity point applicants for additional reference information?

The announcement points applicants to the NIH Guide for Grants and Contracts for additional information.

Who is the FDA grants management contact listed for access or application-related issues?

The listed grants management contact is Vieda Hubbard, Grants Management Specialist. Phone: 301-827-7177. Email: vieda.hubbard@fda.hhs.gov.

Browse more opportunities from the same agency: Food Drug Administration

Browse more opportunities from the same category: Agriculture Business and Commerce Consumer Protection Education Employment, Labor and Training Environment Food and Nutrition Health Information and Statistics Natural Resources

Next opportunity: Site Stewardship in Montana

Previous opportunity: Big Data Aware Terabits Networking

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA FD 13 010

 

[Watch] how do funding administrators access proposals?

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA FD 13 010", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.